Introduction: Behc¸et's disease (BD) is an idiopathic multisystem disorder. Cardiac involvement [cardio-BD] occurs in 7-60% of BD patients. Technetium 99m-Methoxyisobutyl isonitrile (Tc-99m sestamibi) is a myocardial perfusion imaging agent that is used for evaluation of the coronary flow.
Results: SCED detected by reduced flow or left ventricular dysfunction (LVD) or both was found in 13/25 [52%] of BD-patients [12 males and 1 female] vs. 1/15 [6. 7%] of controls [P < 0.0001] with normal CAG. Subjects with positive GSPECT had significantly older age [P = 0.01] and longer disease duration (P = 0.02) and were more frequently males (P < 0.0001) than those with negative GSPECT. No statistically significant differences between cases with negative and positive GSPECT were found regarding other clinical or laboratory parameters.
Conclusion: Tc-99m sestamibi GSPECT could be a useful screening tool for detection of SCED in BD patients, so early prophylactic measures and therapy modifications could be considered.
Introduction
Behc¸et's disease (BD) is a generalized chronic inflammatory disease characterized by a triad of recurrent oral aphthous lesions, genital ulcers and uveitis [1] however, involvement of many other systems is also observed [2] . BD has a wide range of effects on the cardiovascular system resulting in a variety of clinical manifestations. Clinical reports showed cardiac abnormalities in 7-60% of BD patients with mortality prevalence 20% greater in those with vascular involvement [3] [4] [5] [6] including pancarditis, coronary arteritis, acute myocardial infarction, cardiomyopathy and even sudden cardiac death [6] . Vasculitis, a key feature of the disease, may lead to functional disturbances in highly vascularized organs including the heart. Although coagulation disorders have also been reported yet they cannot explain the different thrombotic manifestations which are probably the consequence of an abnormal response of the vascular endothelial cells. Prompt resolution of the symptoms provided by corticosteroid therapy supports the conclusion of previous studies that myocardial ischemia in BD may possibly be due to vasculitis of the coronary arteries [7] .
Cardiac involvement is considered as one of the most important prognostic issues especially when considering the fact that it might be asymptomatic [8] . The term silent myocardial ischemia (SMI) in BD has been stated in three previous reports [4, 6, 9] using radionuclide modality. However, there are some limitations; the available three reports belong only to the Turkish population, hence the need for further studies about BD-induced coronary vascular dysfunction in other communities along the silk route. Additionally, only one report used Technetium-99m methoxyisobutylisonitrile (Tc-99m sestamibi) cardiac gated single photon emission computed tomography (GSPECT) [6] . The latter simultaneously allows the determination of myocardial perfusion, left ventricular ejection fraction (LVEF), and assessment of wall motion [4, 10] with high quality images when compared to thallium-201 [Tl-201] which is not ideal for functional assessment and is more hazardous regarding the patients' radiation exposure [longer half life 73-h vs. 6-h for Tc-99m] with its relatively higher cost, therefore many researchers preferred Tc-99m sestamibi use [11] [12] [13] [14] .
This study was designed to evaluate the usefulness of Dipyridamole pharmacological stress test in conjunction with Technetium 99m-Methoxyisobutyl isonitrile (Tc-99m sestamibi) GSPECT to screen the prevalence of subclinical coronary endothelial dysfunction [SCED] in asymptomatic Egyptian BD patients and to identify those at higher risk for the presence of such abnormalities.
Patients and methods

Study population
The study was approved by the local ethics committee of Cairo-University scientific review board and informed consent was obtained from all subjects according to the Declaration of Helsinki; as revised in 1983. It included twenty-five BD patients (6 females and 19 males, mean age 36.7 ± 9.3 years; range 24-51) who were randomly selected among other BD patients attending the outpatient clinic of the Rheumatology Department, Cairo University Hospitals during 12 months consecutively. They all fulfilled the International Study Group criteria for the classification of BD [2] . Fifteen age, sex and BMI matched healthy subjects with a mean age of 38.5 ± 8.2 years served as control group. All subjects had no clinical evidence of cardiac ischemia or abnormal electrocardiograms (ECG). Subject selection was based on the exclusion of any factors that would affect the coronary arterial circulation as hyperlipidemia, hypertension, diabetes mellitus, family history of cardio-vascular disease, BMI-based obesity, abnormal renal sonography or kidney functions or history of smoking. Routine biochemical analyses were done, after an overnight fast, for all subjects together with complete lipid profile [serum cholesterol, triglyceride, low-density lipoprotein (LDL), and high-density lipoprotein (HDL)].
Behc¸et's Disease Current Activity Form (BDCAF) [15] was used to assess disease activity. Scoring was based on the history of new clinical features present over the preceding 4 weeks prior to assessment. BDCAF scores include oral and genital ulceration; skin, joint, and gastrointestinal involvement; presence of fatigue and headache according to the duration of symptoms. The presence or absence of large vessel involvement was documented. We considered eye activity present if there was a history of blurring of vision or if the eye was painful or red with confirmation by a thorough ophthalmological examination.
Myocardial GSPECT
Dipyridamole-pharmacological stress was used by giving intravenously over 4-6 min [0.56 mg/kg body-weight]. A mild increase in heart rate and mild reduction in blood pressure confirm the drug's pharmacologic effect with imaging after 15 min following dipyridamol infusion. 22-25mCi of Tc-99m sestamibi was injected with continuous ECG and blood pressure monitoring. The stress and rest phases were performed in a 2-day protocol [within one week] with data acquisition using a dual head gamma camera (Philips Axis). Patient position was supine with left arm raised (180°arc); counterclockwise rotation; 128 · 128 Matrix; 64 views image/arc (180°, 45°right anterior oblique and 135°left posterior oblique). In reconstruction; Ramp filter and convolution filter [Butterworth] with oblique angle reformatting [short axis, vertical and horizontal long axes]. In GSPECT; ECG synchronized data collection by R-wave trigger [8 Frames/cardiac cycle] were applied. In the rest phase; imaging was performed 30-60 min after sestamibi administration.
Visual assessment of myocardial perfusion of Left ventricular [LV] walls was done for defects [MPD] . Assignment of the 17 myocardial segments to the territories of the left anterior descending (LAD), right coronary artery (RCA), and the left circumflex coronary artery (LCX) was used.
GSPECT . We classified the study subjects into GSPECT negatives and positives [SCED]. Stress induced stunning was considered when LVD was detected in association with normal perfusion pattern. SCED was diagnosed in positive GSPECT cases using the following criteria: [1] reduced blood flow to any of the left ventricular walls, [2] LVD or [3] both were found. Coronary angiography [CAG] was done in all MPD positives using Judkin's technique. Stenoses of coronary vessels were coded according to the American Heart Association Criteria [16] .
Statistical analysis: The data were analyzed by statistical package for the social science (SPSS) version 14. Continuous data were presented as means ± standard deviations (SD), while discrete data were shown as numbers and percentages. Cross tabulation was utilized to describe the relations between variables using the contingency coefficient. Levene's test (Ftest) for the equality of variances was used and t-test for testing the differences between parametric data. Comparison between non-parametric variables was performed using the Mann-Whitney U-test. Significance was defined as P < 0.05 throughout.
Results
Study population
Our 25 BD patients (19 males, 76%, and 6 females, 24%) had mean disease duration of 5.75 year ± 3.6. Their clinical characteristics are shown in Table 1 . Twenty-two patients (88%) were on oral prednisone (5-20 mg/day; mean, 10.4 ± 7.3) and colchicine, 8 (32%) on IV cyclophosphamide pulses, 11 (44%) on azathioprine, 10 (40%) on oral anticoagulants, 2 (8%) on nonsteroidal anti-inflammatory drugs, 2 (8%) on methotrexate (MTX), and one (4%) patient uses chlorambucil. The laboratory data of the studied cases were within normal limits including LDL, HDL, triglycerides, and serum cholesterol and the comparison between the lipid profile mean values in BD and controls was not statistically significant 
Myocardial GSPECT Imaging and Coronary Angiography
Positive GSPECT was found in 13/25 BD patients (52%) without ECG abnormalities [12/19 (63.2%) males and 1/6 (16.7%) females; P < 0.0001] compared to 1/15 (6.7%) in the control group being a male who had mild hypoperfusion in the anterior wall (P < 0.0001) ( Table 3 ; Fig. 1 and 2) . Regarding reduced blood flow to any of the left ventricular walls; it was found in 12 BD cases where 9/12 (75%) and 3/12 (25%) BD patients had mild and moderate stress induced hypoperfusion denoting SCED in LAD (9 patients), RCA (5 patients) and LCX (1 patient) vascular territories Table 3 . Regarding LVD; it was found in 11/25 BD patients compared to none of the controls (P < 0.0001) Table 3 . The 11/13 GSPECT positives had abnormal LV-WM [hypokinesia] with mildly reduced LVEF [contractile power] in only three of them; however in one case stress-induced stunning [Abnormal reduction in stress LVEF that normalizes in the rest phase] was found Table 4 . CAG was done for the 13 GSPECT positives and showed no coronary stenosis. The positive control subject refused to undergo CAG.
Comparison between BD patients with normal and abnormal myocardial GSPECT
Patients with abnormal positive GSPECT had significantly older age than those with negative GSPECT (46.7 years ± 5.3 vs. 31.7 ± 6.3) (P = 0.01) and were more frequently males (11 males vs. 1 female) (P < 0.001). No significant difference was elicited between the %LVEF stress means of positive or nega- tive GSPECT BD cases (51.7 ± 9.4 vs. 53 ± 5.1 respectively). A statistically significant difference was found between both groups regarding disease duration (7.3 years ± 2.1 in positive vs. 3.2 ± 1.8 in negative) (P = 0.02), while no significant differences were found regarding BDCAF, frequency of active eye disease, history of medication and other BD clinical manifestations.
Discussion
This study was carried out on 25 Egyptian BD patients without overt clinical cardiac ischemia and showed a high prevalence of subclinical coronary vascular dysfunction compared to controls (13 vs. 1) as detected by Dipyridamole stress GSPECT with no corresponding coronary stenoses in CAG.
As far as we are aware; no prior studies suggested pharmacological stress testing in conjunction with sestamibi GSPECT in BD patients as a screening test for SCED in the coronary circulation. Vascular endothelial dysfunction [VED] was detected in the earliest stages of atherosclerosis [17] [18] [19] and its detection is considered among the important prognostic factors in BD patients [8] .
The diverse spectrum of cardiovascular involvement in BD was recognized since 1946 and considered to be peculiar as it occurs in young subjects with no vascular risk factors [21] . It includes coronary artery disease which is often expressed by myocardial infarction or angina with a relatively high mortality [20] .
On the other hand, a healthy endothelium is a monolayer of cells located between the blood and the underlying tissues that plays an important role in the regulation of vascular tone, balance between effects of relaxing and contracting factors, thrombosis, vascular inflammation, and smooth muscle cell proliferation. VED is characterized by reduced vasodilation which is also by itself a prothrombotic and proinflammatory state and was found in essential hypertension, diabetes, coronary heart disease, chronic renal failure [21] [22] [23] [24] , rheumatoid arthritis and systemic lupus erythematosus [25] . The presence of VED in BD patients was first reported by Chambers et al. study [26] and could be associated with reduced systemic fibrinolytic activity that may lead to myocardial infarction or acute coronary syndrome [27] . The presence of vasculitis may result in significant impairment of endothelial cell function in BD with subsequently reduced endothelium-derived vasodilator that could lead to vasoconstriction, platelet aggregation and monocyte adhesion contributing to vascular disease [26] .
Generally, macrovascular pathologies are recognized by clinical history, physical examination, Doppler ultrasonography and angiography while microvascular disorders may be investigated by laser Doppler and capillary microscopy [28] . VED can be assessed by endothelium-dependent vasodilatation measuring tests [21] [22] [23] [24] which are based mainly on the stimulation of endothelial nitric oxide release that could be achieved either by infusion of vasoactive substances like acetylcholine or by inducing transient ischemia as in flow-mediated dilatation of the brachial artery where a pneumatic cuff is inflated for 5-min over the forearm to cause arterial occlusion [Transient ischemia] [24] . On the other hand, Dipyridamole is an indirect coronary vasodilator that works by increasing intravascular adenosine through inhibition of phosphodiesterase that prohibits reuptake of endogenously produced adenosine into endothelial and red blood cells leading to arteriolar vasodilatation. This increases coronary arterial flow to approximately three times of resting values in the healthy endothelial state, however it is attenuated in diseased coronary arteries that cannot further dilate in response to adenosine. So, Dipyridamole infusion produces a relative flow heterogeneity throughout coronary arteries, resulting in relatively more coronary blood flow in healthy arteries compared with the diseased-arteries as in vasculitis inducing ischemia via a ''coronary steal phenomenon'' with subsequent perfusion defects [hypoperfusion] ± abnormal LV-WM during radionuclide imaging [29, 30] . Hence, we used Dipyridamole stress in conjunction with Tc-99m sestamibi GSPECT as a screening tool for SCED of the coronary circulation in BD patients.
Asymptomatic myocardial ischemia in BD was documented and defined as SMI [4, 31] ; it was postulated that autonomic nervous system dysfunction in BD patients [32] might be responsible for its silence as neuropathic damage to the myocardial sensory afferent fibers in the autonomic nerve supply reduces the individual's sensitivity to ischemia by interrupting pain transmission [4] . Thus, our study was conducted for SCED screening of the coronaries in asymptomatic BD population. Regarding their demographic characteristics; male/fe- male ratio was 3:1 that was reported to be 1.3:1 and 2:1 in other similar studies [4, 6] . However, their mean age (36.7 ± 9.3 years) was comparable to that of previous reports [4, 6, 9] . The reported increased frequency of male involvement may be explained by the higher incidence of systemic complications and more severe disease in men, possibly bringing them to earlier medical attention [33] .
In the current study, no stress ECG changes were elicited in the GSPECT positive cases. It was previously stated that even if ECG was normal, GSPECT might be abnormal [34, 35] . Gullu et al. [9] reported SMI in 25% of BD patients vs. 2.6% in controls using ambulatory ECG monitoring; 89% of them had reversible perfusion defects by radionuclide imaging. Also, Turkolmez et al. [4] showed ischemic changes in 19.5% of BD patients compared to 2.9% in controls. However, in the aforementioned two studies Thallium-201 (Tl-201) was used without gated functional assessment while in our study we used Dipyridamole stress Tc-99m sestamibi GSPECT with a higher prevalence of SCED than in controls (52% vs. 6.7%). Our findings concur with Kaya et al. study [6] where coronary vascular dysfunction was found in 13/23 (56.5%) of BD patients vs. 2/10 of controls (10.0%). In our study, LAD was the most frequently affected followed by RCA and LCX respectively which is in agreement with other reports [6, 9, 36, 37] .
In the present study; LVD was found in 44% of BD patients vs. none of the controls with hypokinesia as the only form of LV-WM abnormality mostly in the anterior wall and this concurs with Kaya et al. and Gemici et al. studies [6, 31] , however Kaya et al. investigated other functional parameters that were not enrolled in our study. In one of our BD patients ''stunning'' was detected which is a stressinduced acute transient myocardial ischemia manifested by reduced LVEF and abnormal LV-WM with apparently normal coronary flow that persists for several hours but is eventually followed by functional recovery [38] . Repetitive episodes of stunning can be cumulative and lead to more prolonged LVD and such abnormality is thought to be a causative mechanism for future cardiomyopathy and heart failure [38, 39] . Be- sides, to our knowledge we are the first to report such a phenomenon in BD patients.
CAG showed no significant coronary stenoses in BD patients with positive GSPECT in the current study. Concordant outcomes were reported in similar studies; where none of the BD population in Tu¨rko¨lmez et al. study [4] showed CAG abnormalities, while vast majority of the BD positives in Kaya et al. and Gu¨llu¨et al. studies were CAG negative [6, 9] . Kosar et al. reported acute MI in a young BD male patient diagnosed by ECG with normal CAG [27] . This non concordance between CAG and radionuclide imaging may be explained as the latter delineates the subclinical impairment in coronary microcirculation and altered coronary vasomotor activity secondary to endothelial dysfunction on top of vasculitis, while CAG shows only macrovascular abnormalities [4, 9, 40] .
No significant difference was found between positive and negative Gated-SPECT cases regarding BD clinical parameters, except for age, gender and disease duration. SCED was detected in older ages and longer disease duration; this agrees with other reports [4, 6, 9] and Ugurlu et al. questionnaire [41] , who assessed the prevalence of angina and ischemic heart disease in BD and stated that affected patients were more likely to be older and hypertensive and less likely to smoke while the rest of atherosclerotic risk factors were similar between patients and controls. The same applies for the male predominance in GSPECT positives cases as the male/female ratio was 3:1 as in Tu¨rko¨lmez et al. and Kaya et al. studies [4, 6] . Besides, the medication history showed no significant difference between the BD GSPECT positive and negative cases; and this agrees with earlier studies [4, 6] .
Finally, our main limitation is the small sample size [both patients and controls], however our main strength is the suggestion of cardiac assessment by using Dipyridamole stress in conjunction with Tc-99m sestamibi GSPECT. Such a methodology can display reduced coronary flow and LVD at an early stage of BD providing a better understanding of hemocirculatory and metabolic features of the illness. Also, it can allow the monitoring of patient's clinical condition and possibly treatment response. It is evident that SCED in BD must be diagnosed precociously; GSPECT as a complementary modality can be of great help that may omit the need for CAG, and even when being normal, it can exclude the presence of active coronary vasculitis.
It might be concluded that dipyridamole stress GSPECT myocardial perfusion imaging can be effectively used to diagnose preclinical coronary vascular endothelial dysfunction in Behc¸et's disease and might be utilized for evaluating cardiac involvement as a mirror image of active coronary vasculitis. We believe it has a place as a screening tool for SCED considering the fact; whenever the diagnosis, the better is the result.
